Developing Irritable Bowel Syndrome Guidelines Through Meta-analyses: Does the Emperor Really Have New Clothes?

Gastroenterology

Volumn 137, Issue 3, 2009, Pages 766-769

  Camilleri, Michael ^a   Mayer, Emeran A ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CIMETROPIUM; DESIPRAMINE; ISPAGULA; MEBEVERINE; MUSCLE RELAXANT AGENT; OTILONIUM BROMIDE; PROBIOTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMEBUTINE;

CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HUMAN; IRRITABLE COLON; MEDICAL INFORMATION; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 69249111401     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.07.030     Document Type: Editorial

References (23)

1. Brandt L.J., Chey W.D., Foxx-Orenstein A.E., et al. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol 10 (2009) S1-S35
2. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
3. Klein K.B. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 95 (1988) 232-241
4. Brenner D.M., Moeller M.J., Chey W.D., et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 104 (2009) 1033-1049
5. Moayyedi P., Ford A.C., Talley N.J., et al. The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review. Gut (2008 Dec 17) [Epub ahead of print]
6. Drossman D.A., Toner B.B., Whitehead W.E., et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 125 (2003) 19-31
7. Ford A.C., Talley N.J., Schoenfeld P.S., et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58 (2009) 367-378
8. Rahimi R., Nikfar S., Rezaie A., et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 15 (2009) 1548-1553
9. Vahedi H., Merat S., Rashidioon A., et al. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther 22 (2005) 381-385
10. Vahedi H., Merat S., Momtahen S., et al. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 27 (2008) 678-684
11. Quartero A.O., Meineche-Schmidt V., Muris J., et al. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2 (2005) CD003460
12. Thiwan S., Drossman D.A., Morris C.B., et al. Not all side effects associated with tricyclic antidepressant therapy are true side effects. Clin Gastroenterol Hepatol 7 (2009) 446-451
13. Lackner J.M., Jaccard J., Krasner S.S., et al. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol 6 (2008) 899-906
14. Zijdenbos I.L., de Wit N.J., van der Heijden G.J., et al. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 1 (2009) CD006442
15. Ford A.C., Talley N.J., Spiegel B.M., et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 337 (2008) a2313
16. Poynard T., Regimbeau C., and Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 15 (2001) 355-361
17. Poynard T., Naveau S., Mory B., et al. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 8 (1994) 499-510
18. Hoveyda N., Heneghan C., Mahtani K.R., et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 9 (2009) 15
19. McFarland L.V., and Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 14 (2008) 2650-2661
20. Nikfar S., Rahimi R., Rahimi F., et al. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 51 (2008) 1775-1780
21. Andresen V., Montori V.M., Keller J., et al. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 6 (2008) 545-555
22. Evans B.W., Clark W.K., Moore D.J., et al. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev 4 (2007) CD003960
23. Lesbros-Pantoflickova D., Michetti P., Fried M., et al. Meta-analysis: the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 20 (2004) 1253-1269